<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="239461" id="root" date="1996-12-06" xml:lang="en">
<title>USA: Orphan Medical launches first two products.</title>
<headline>Orphan Medical launches first two products.</headline>
<dateline>MINNEAPOLIS 1996-12-06</dateline>
<text>
<p>Orphan Medical Inc said Friday its first two drugs, Cystadane and Elliotts B Solution, are now commercially available.</p>
<p>Cystadane is the first drug that can be used to treat homocystinuria, a rare genetic disorder, said Orphan Medical. The condition can lead to mental and developmental retardation, nerve disorders, skeletal abnormalities and other manifestations.</p>
<p>Elliotts B Solution is used to treat meningeal leukemia or lymphocytic lymphoma, said the company.</p>
<p>Orphan Medical develops drugs for patients with inadequately treated or uncommon diseases.</p>
<p>((Chicago newsdesk (312) 408-8787))</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-06"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C22">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-06"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-06"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-12-06"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-12-06"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="MINNEAPOLIS"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
